The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Asia Pac J Public Health. 2021 Jul;33(5):502-507. doi: 10.1177/10105395211027467. Epub 2021 Jun 29.
Native Hawaiian and Pacific Islander (NHPI) adults bear a disproportionate burden of certain human papillomavirus (HPV)-associated cancers. In 2015, data from the National Health Interview Survey (NHIS) showed vaccination coverage among adults by racial and ethnic groups; however, coverage data for NHPI adults were unavailable. In this study, we estimated the initiation and completion of HPV vaccination and assessed the factors associated with vaccination among NHPI adults aged 18 to 26 years in the United States. We analyzed public data files from the 2014 NHPI NHIS (n = 1204). We specified sampling design parameters and fitted weighted logistic regression models to calculate the odds of HPV vaccine initiation. We developed a directed acyclic graph to identify a minimally sufficient set for adjustment and adjusted for insurance coverage (for education and ethnicity) and doctor visit (for insurance coverage, earnings, ethnicity, and sex). Overall, 24.9% and 11.5% of NHPI adults had initiated and completed the HPV vaccination series, respectively. Weighted logistic regression models elucidated that the odds of HPV vaccine initiation were higher for females (weighted odds ratio = 5.4; 95% confidence interval = 2.8-10.4) compared with males. Low vaccination coverage found among NHPI adults provides an opportunity for targeted programs to reduce the burden of HPV-associated cancers.
美国本土夏威夷原住民和太平洋岛民(NHPI)成年人患某些人乳头瘤病毒(HPV)相关癌症的比例过高。2015 年,国家健康访谈调查(NHIS)的数据显示了按种族和民族划分的成年人疫苗接种率;然而,无法获得 NHPI 成年人的疫苗接种数据。在这项研究中,我们估计了美国 18 至 26 岁的 NHPI 成年人 HPV 疫苗接种的起始和完成情况,并评估了与疫苗接种相关的因素。我们分析了 2014 年 NHPI NHIS 的公共数据文件(n=1204)。我们指定了抽样设计参数,并拟合了加权逻辑回归模型来计算 HPV 疫苗接种起始的可能性。我们开发了一个有向无环图来确定最小的调整集合,并根据保险覆盖范围(用于教育和种族)和医生就诊(用于保险覆盖范围、收入、种族和性别)进行调整。总体而言,24.9%和 11.5%的 NHPI 成年人分别开始和完成了 HPV 疫苗接种系列。加权逻辑回归模型表明,女性(加权优势比=5.4;95%置信区间=2.8-10.4)接种 HPV 疫苗的可能性高于男性。在 NHPI 成年人中发现的低疫苗接种率为有针对性的项目提供了一个机会,以减轻 HPV 相关癌症的负担。